SLE (Systemic Lupus) Clinical Trial
Official title:
National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06063668 -
Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients
|
||
Completed |
NCT05624437 -
BElimumab corticoSteroids Sparing Treatment in Systemic Lupus Erythematosus
|
||
Recruiting |
NCT06445127 -
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
|
N/A | |
Recruiting |
NCT04866615 -
Posterior Segment Evaluation of Patients With SLE Using OCT and OCTA
|
||
Not yet recruiting |
NCT04645225 -
Clinical Characteristic and MEFV Gene Mutations in Patient With Juvenile Onest Systemic Lupus Erythematosus
|
||
Recruiting |
NCT06150651 -
Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.
|
Phase 1 | |
Recruiting |
NCT06056921 -
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
|
Phase 1 | |
Recruiting |
NCT06294236 -
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
|
Phase 1 | |
Recruiting |
NCT05866861 -
A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus
|
Phase 1 |